Improved RCC I/II-data

• 09:13

Immunicum AB (publ) today announced continued improvement in survival data from the follow-up phase of a clinical phase I/II trial in patients with metastatic renal cell cancer. Seven of eleven evaluable patients are still alive.

Read the press release here: Press release 150804 – RCC-update

Deprecated: Theme without comments.php is deprecated since version 3.0.0 with no alternative available. Please include a comments.php template in your theme. in /home/i/immunicu/www/wp-includes/functions.php on line 4973

Comments are closed.